Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDM06
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $122,843.40 to DMS Pharmaceutical Group Inc. on September 22, 2025, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, will be performed at the contractor's facility in Park Ridge, Illinois. The award was issued without a set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis in the federal pharmaceutical procurement market.
DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that serves as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain, holding a substantial single-award Indefinite Delivery Contract valued at $499,999,999 through November 2026 under the SPE2DB program. This delivery order represents a specific fulfillment under that larger vehicle, which authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. The company's extensive portfolio of federal contracts demonstrates its established capability to deliver specialized pharmaceutical products, including oncology treatments like Keytruda, to military health systems.
Quick answers
Who was awarded contract SPE2DB25FDM06?
SPE2DB25FDM06 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FDM06 worth?
The government has obligated $122,843 on SPE2DB25FDM06.
Is contract SPE2DB25FDM06 an order under another contract?
Yes. SPE2DB25FDM06 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM06 competed?
The extent of competition for SPE2DB25FDM06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award